• Company
• Imfinzi combo drug Imjudo can be prescribed at hospitals
• by Eo, Yun-Ho Nov 13, 2024 05:54am

• Company
• Treatment-refractory Dravet syndrome calls for new options
• by Whang, byung-woo Nov 13, 2024 05:54am

• Company
• 'Choline alfoscerate' prescription market continues to grow
• by Chon, Seung-Hyun Nov 13, 2024 05:54am

• Company
• Asthma drug 'Monterizine' sales rise despite generic entries
• by Kim, Jin-Gu Nov 12, 2024 05:51am

• Company
• 'Vabysmo' for macular deg associated RVO indication expected
• by Eo, Yun-Ho Nov 12, 2024 05:51am

• Company
• Generic companies seek early entry into KRW 100 bil Tagrisso
• by Kim, Jin-Gu Nov 12, 2024 05:51am

• Company
• Will Lorviqua be reimbursed as a first-line therapy in KOR?
• by Eo, Yun-Ho Nov 11, 2024 05:49am

• Company
• Companies copromote products at Hypertension Seoul 2024
• by Kim, Jin-Gu Nov 11, 2024 05:49am

• Company
• 'Voranigo' for malignant brain tumor expected to land in KOR
• by Eo, Yun-Ho Nov 11, 2024 05:49am

• Company
• K-Bios showcases new ADC drugs on the international stage
• by Son, Hyung Min Nov 11, 2024 05:49am